Nanotechnologies in Drug Delivery Conference
News Jan 28, 2015
Technology Networks is pleased to announce that it has entered into a media partnership with MnM Conferences, the organisers of Nanotechnologies in Drug Delivery Congress. The meeting takes place on the 27 – 28 April 2015 and will be held in London, United Kingdom.
Leading academics, scientists and business development executives from pharma and biotech companies from around the world will be travelling to the Nanotechnologies in Drug Delivery Congress. This event puts them together with venture capitalists and other financiers looking to invest in their projects.
Bringing together 25+International expert speakers from academia and industry, the two day program will examine key concerns in drug delivery including Nanotechnology drug enabled drug delivery in HIV therapy, siRNA, and blood protein analysis as well as exploring nanotechnology in medicine design.
• The role of technology is fundamental to the way we respond to healthcare challenges
• Growth of innovative drug delivery platforms – Importance & Benefits
• Imaging Nanotechnogies fate in vivo: a help to faster drug delivery preclinical studies
• siRNA - Providing a completely new paradigm for disease treatment
• Personalised cancer medicine mediated by pharmacogenomics and tailored immunotargeting via nanotechnology
• Delivery across blood brain barriers using nano needles
• Exploring nanotechnology in medicine design
Panel Discussion - Safety Issues of Nanoparticles for Diagnostics
Panel Discussion - Successfully sourcing new technologies from both academia and the industry
Panel discussion – Cutting cost on delivery and formulations
The full agenda can be found at the event website
Technology Network subscribers can save 20% off on the delegate registration if you register your seat before 15th Feb 2015! Just use NST/ND/20 as a discount code. So hurry to get an amazing deal !
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Drug-Delivery System Can Help Heal Even Without DrugsNews
A particular hydrogel, a self-assembling multidomain peptide (MDP) with the amino acid sequence K2(SL)6K2, is bioactive. Researchers found that even without additives their MDP is rapidly infiltrated by host cells, provokes a temporary inflammatory response, does not develop a fibrous capsule, supports the infiltration of a mature vascular network and recruits nerve fibers.READ MORE
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018